Chemi Nutra Signs Patent Licensing Agreement

Chemi Nutra Signs Patent Licensing Agreement

WHITE BEAR LAKE, Minn.Chemi Nutra is now an exclusive licensee on a use patent (U.S. Patent No. 6,673,378) assigned to Robert Fritz that involves phophatidylserine (PS) and muscle development. The patent discusses the ability of soy-derived PS to suppress stress-related elevations in cortisol, inhibiting protein catabolism and improving recovery. Chemi Nutra supplies SerinAid® PS.

The issuance of this significant patent is the culmination of seven years of intensive investigation, research and ongoing discussion, said Scott Hagerman, president of Chemi Nutra (www.cheminutra.com). Our collaboration demonstrates Chemi Nutra's commitment to the nutritional supplement industry, and we are excited about the physiological benefits that PS provides to those interested in managing their stress and body compositions, and gaining the ultimate competitive edge.